CTOs on the Move


 
Metamark Genetics, Inc. is a privately held biotechnology company founded in 2007 to develop novel, function-based, prognostic and diagnostic tests aimed at improving cancer care. The company's proprietary genomic and proteomic discovery platforms have yielded significant discoveries in several disease areas, including prostate, colon, and breast cancers. In early 2014, Metamark plans to commercialize ProMark™—its prostate cancer prognostic test—through its Cambridge, Massachusetts CLIA-certified laboratory. For more information, please visit the company's Website at www.metamarkgenetics.com. Metamark™ and ProMark™ are trademarks of Metamark Genetics, Inc.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Penn State Health Milton S. Hershey Medical Center

Penn State Health Milton S. Hershey Medical Center, Penn State College of Medicine and The Children`s Hospital at Penn State Health Milton S. Hershey Medical Center are committed to enhancing the quality of life through improved health, the professional preparation of those who will serve the health needs of others, and the discovery of knowledge that will benefit all.

EMQ FamiliesFirst

EMQ FamiliesFirst is a Campbell, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MediSystem Technologies

MediSystem Technologies Inc. is a North York, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Health Care Excel Inc

Health Care Excel Inc is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.